This inventor holds 27 USPTO granted patents and 10 published patent applications, plus 7 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Abbvie Inc., Abbott Laboratories Corporation. Active years: 2007-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2019
Areas of Expertise:
Title: Innovations of Kenton L Longenecker
Introduction
Kenton L Longenecker, based in Grayslake, IL, has made significant contributions to the field of biopharmaceutical research, holding 27 patents to his name. His inventions focus on crucial aspects of immunology and oncology, showcasing his dedication to advancing medical science.
Latest Patents
Among his latest innovations are two notable patents. The first, titled "Tricyclic modulators of TNF signaling," provides a range of tricyclic heterocyclic compounds. These compounds include pharmaceutically acceptable salts and biologically active metabolites, which may prove beneficial in treating various immunological and oncological conditions. The second patent, "Prolactin receptor binding proteins and uses thereof," encompasses innovative PRLR binding proteins. This invention specifically involves chimeric, CDR grafted, and humanized antibodies with high affinity for the human prolactin receptor (hPRLR). These antibodies are designed to neutralize hPRLR activity and have applications in diagnosing and treating disorders related to detrimental hPRLR activity, including the development of antibody-drug conjugates.
Career Highlights
Kenton has had an impactful career working with leading pharmaceutical companies, including AbbVie Inc. and Abbott Laboratories Corporation. His work at these institutions has enabled him to engage in groundbreaking research and contribute to the development of novel therapeutic agents.
Collaborations
During his career, Kenton L Longenecker has collaborated with notable professionals in the industry, including Kent D Stewart and Rolf Wagner. These collaborations have fostered innovation and driven projects that push the boundaries of existing medical knowledge.
Conclusion
Kenton L Longenecker's achievements in securing numerous patents reflect his commitment to advancements in the field of biopharmaceuticals. His contributions have the potential to make a significant impact on the treatment of immunological and oncological conditions, showcasing the importance of innovation in the medical sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile